Benutzer: Gast  Login
Dokumenttyp:
journal article 
Autor(en):
Herrmann, K; Buck, AK; Schuster, T; Junger, A; Wieder, HA; Graf, N; Ringshausen, I; Rudelius, M; Wester, HJ; Schwaiger, M; Keller, U; Dechow, T 
Titel:
Predictive value of initial 18F-FLT uptake in patients with aggressive non-Hodgkin lymphoma receiving R-CHOP treatment. 
Abstract:
R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone)-like chemotherapy is the standard therapy in aggressive B-cell lymphoma. (18)F-FDG PET has high prognostic implications at treatment completion but is limited as an early predictor. Here, we present the results of a prospective study correlating the initial uptake of the in vivo proliferation marker 3'-deoxy-3'-(18)F-fluorothymidine ((18)F-FLT) with the clinical outcome of patients with aggressive non-Hodgkin lymphoma...    »
 
Zeitschriftentitel:
J Nucl Med 
Jahr:
2011 
Band / Volume:
52 
Heft / Issue:
Seitenangaben Beitrag:
690-6 
Sprache:
eng 
Print-ISSN:
0161-5505 
TUM Einrichtung:
Nuklearmedizinische Klinik und Poliklinik; r Medizinische Statistik und Epidemiologie; III. Medizinische Klinik und Poliklinik; r Allgemeine Pathologie und pathologische Anatomie